CEL-SCI and Saudi Amarox Formalize Partnership at BIO 2026 to Advance Oncology Innovation in Saudi Arabia CEL-SCI Corporation announced that it has officially completed a formal signing ceremony with Saudi…
Javelin Biotech Publishes Multi-Tissue Chip and PBPK Study Showing Potential to Predict Human Drug Pharmacokinetics Without Animal Data Javelin Biotech has announced the publication of a new scientific study that…
HighRes and Waters Biosciences Partner to Bring Robotic Automation to Flow Cytometry Workflows HighRes has announced a strategic collaboration with Waters Biosciences aimed at expanding robotic automation capabilities for flow…
Merck KGaA Teams With Saturnus Bio to Build Precision Cardiology Portfolio for Rare Genetic Cardiomyopathies Merck KGaA, Darmstadt, Germany has entered a strategic research-stage collaboration with Saturnus Bio, a biotechnology…
Cynosure Lutronic’s XERF Surpasses 2,000 Installations Worldwide, Highlighting Growing Demand for Non-Invasive Skin Tightening Cynosure Lutronic has reached a new commercial milestone for XERF™, its multifrequency monopolar radiofrequency platform for…
VectorBuilder and MaxCyte Partner to Develop Next-Generation Non-Viral Gene Delivery Platform for Ex Vivo Cell Therapies VectorBuilder and MaxCyte have entered into a strategic partnership aimed at developing a next-generation…
Dexcom Expands Access to Glucose Biosensing With Pediatric Clearance for Stelo and New App Rollout Plans DexCom, Inc. is broadening its push into preventive and personalized metabolic health with a…
Vyriad Reshapes Executive Leadership Team as It Prepares for Next Phase of Growth in In Vivo CAR T and Viral Delivery Therapies Vyriad, Inc., a clinical-stage biotechnology company focused on…
Alpha Cognition Appoints Robert Wills as Chairman of the Board as Company Advances ZUNVEYL Launch and Neurodegenerative Pipeline Alpha Cognition Inc. has announced a key leadership transition at the board…
DiaMedica Begins Phase 2 Clinical Evaluation of DM199 in Fetal Growth Restriction as First Patients Receive Treatment DiaMedica Therapeutics has reached an important clinical milestone in its effort to address…
HistoSonics Raises New Financing to Expand Histotripsy Platform Across Solid Tumors HistoSonics, the medical technology company behind the Edison® Histotripsy System, has closed a new financing round backed by Reed…
Arrowhead Pharmaceuticals Wins EU Approval for REDEMPLO® to Lower Triglycerides in Adults with Familial Chylomicronemia Syndrome Arrowhead Pharmaceuticals has secured an important regulatory milestone in Europe with the European Commission’s…